医学
脂肪肝
氧化应激
内科学
丙二醛
超氧化物歧化酶
油红O
内分泌学
汤剂
促炎细胞因子
谷胱甘肽
药理学
作者
Yang Jiayao,Tao Dongqing,M A Wei,Liu Song,Liao Yan,Shu Lei,Zhang Shu,L I Chenyu,D U Nianlong
出处
期刊:Journal of Traditional Chinese Medicine
[Elsevier]
日期:2022-10-01
卷期号:42 (5): 773-780
标识
DOI:10.19852/j.cnki.jtcm.2022.05.009
摘要
To investigate the protective effects and molecular mechanisms of Lizhong decoction (, LZD) against non-alcoholic fatty liver disease (NAFLD).Male Wistar rats were fed a high-fat diet for four weeks to induce NAFLD, and were administered LZD by gavage for four weeks. Potential therapeutic targets for NAFLD were analyzed using network pharmacology. Liver pathology was evaluated using Oil Red O and hematoxylin-eosin staining. Furthermore, mitochondrial function, lipid metabolism, oxidative stress, and inflammatory response were examined.Rats with NAFLD exhibited high levels of hepatic damage and cholesterol deposition. Moreover, apoptosis was increased, superoxide dismutase and glutathione content were reduced, malondialdehyde content was increased, and the protein expression of inflammatory cytokines and p-c-Jun N-terminal kinase was increased. The LZD treatment ameliorated mitochondrial dysfunction, reduced liver damage, inhibited oxidative stress and inflammatory response, upregulated peroxisome proliferator-activated receptor (PPAR)-γ expression, and suppressed dipeptidyl peptidase 4 (DPP4) expression in the liver.It was found that LZD alleviates NAFLD by activating PPAR-γ and inhibiting DPP4.
科研通智能强力驱动
Strongly Powered by AbleSci AI